Tested Applications
| Positive WB detected in | MCF-7 cells, U2OS cells, K-562 cells, mouse spleen tissue, NIH/3T3 cells, PC-12 cells |
| Positive IHC detected in | human prostate cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26948-1-AP targets USP7 in WB, IHC, IF, RIP, ELISA applications and shows reactivity with human, mouse, rat samples.
| Tested Reactivity | human, mouse, rat |
| Cited Reactivity | human, mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag25634 Product name: Recombinant human USP7 protein Source: e coli.-derived, PGEX-4T Tag: GST Sequence: MLLDNVENKMKGTCVEGTIPKLFRGKMVSYIQCKEVDYRSDRREDYYDIQLSIKGKKNIFESFVDYVAVEQLDGDNKYDAGEHGLQEAEKGVK Predict reactive species |
| Full Name | ubiquitin specific peptidase 7 (herpes virus-associated) |
| Observed Molecular Weight | 126-128 kDa |
| Gene Symbol | USP7 |
| Gene ID (NCBI) | 7874 |
| RRID | AB_2880696 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q93009 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for USP7 antibody 26948-1-AP | Download protocol |
| WB protocol for USP7 antibody 26948-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
USP7 antibody (Cat# 26948-1-AP) has 18 total citations published in journals including Cancer Research, Cell Death & Disease, PNAS, International Journal of Biological Sciences, British Journal of Cancer, Frontiers in Immunology, Journal of Neuroimmune Pharmacology, European Journal of Pharmacology, Molecular Neurobiology, Frontiers in Pharmacology, Translational Oncology, Cell Signaling, ACS Pharmacology & Translational Science, FEBS Letters, Discovery Oncology, Virology, and International Journal of Biological Macromolecules. Research fields span oncology, immunology, neuroscience, cardiology, epigenetics, and virology.
| Species | Application | Title |
|---|---|---|
Cancer Res Targeting USP7 identifies a metastasis-competent state within bone marrow-resident melanoma CTCs. | ||
Int J Biol Sci Flap endonuclease 1 Facilitated Hepatocellular Carcinoma Progression by Enhancing USP7/MDM2-mediated P53 Inactivation. | ||
Proc Natl Acad Sci U S A High-throughput screening identifies a critical role of the SPOP-PABPC1 axis in lung adenocarcinoma progression. | ||
Int J Biol Macromol The USP7-VIM axis mediates lipid metabolic remodelling and compromises CD8(+) T-cell mitochondrial fitness in glioblastoma. | ||
Br J Cancer Suppression of LRRC41-mediated oncogenicity in hepatocellular carcinoma via USP7-targeted small molecule inhibitors.
|















